TET2 and breast cancer: In MCF7 cell lines, the activated ERα could firstly promote the expression of DNA methyltransferase (DNMT), which further mediated the promoter methylation of TET2, resulting in gene silencing as well as low levels of DNA hydroxymethylation in breast cancer [49].